Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Stoppen met nucleos(t)ide-analogen bij HBeAg-negatieve chronische hepatitis B?
aug 2023 | Hepatitis, Hepatologie